Oklo (NYSE:OKLO – Get Free Report) issued its earnings results on Friday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.12), Zacks reports. The firm had revenue of $1.21 million for the quarter, compared to analyst estimates of $0.09 million. During the same period last year, the firm posted ($0.18) EPS. The company’s quarterly revenue was up 11900.0% on a year-over-year basis.
Here are the key takeaways from Oklo’s conference call:
- Groves reached first criticality after transitioning from a greenfield site to an operating isotope reactor in just over 11 months, according to management. Oklo said the project validated its construction, authorization, commissioning, and operating capabilities for future deployments.
- Aurora-INL advanced with DOE approval of its preliminary documented safety analysis, site mobilization, and reactor-area excavation nearing completion; the company continues to target a 2028 startup. Oklo also expanded Ohio campus execution planning through an MOU with Kiewit and continued PJM interconnection work.
- Oklo is pursuing a diversified fuel strategy spanning EBR-II material, a potential DOE plutonium allocation, Centrus commercial HALEU, and future recycling. The Centrus letter of intent could support initial core and reload needs for up to five Aurora powerhouses, although it remains subject to a definitive agreement and deliveries are expected from 2029.
- The company strengthened its vertically integrated platform through acquisitions of ARMEC and Creative Engineers, adding engineering, manufacturing, testing, and sodium-systems capabilities. Oklo also highlighted collaborations with NVIDIA, Los Alamos National Laboratory, and DOE initiatives to apply AI to fuel qualification, reactor design, and operational workflows.
- Oklo raised its 2026 guidance for operating cash use to $120 million–$150 million from $80 million–$100 million and property, plant, and equipment spending to $400 million–$500 million from $350 million–$450 million. The company ended the quarter with more than $3 billion in cash and marketable securities, but isotope revenue is not expected to begin meaningfully until potentially early 2027, primarily from the Idaho laboratory rather than Groves.
Oklo Trading Up 14.7%
Shares of NYSE OKLO traded up $6.19 during midday trading on Friday, reaching $48.38. 22,043,558 shares of the company were exchanged, compared to its average volume of 8,689,262. The stock has a market cap of $8.42 billion, a P/E ratio of -57.59 and a beta of 1.17. Oklo has a 1 year low of $36.61 and a 1 year high of $193.84. The stock has a fifty day simple moving average of $50.88 and a 200 day simple moving average of $60.58.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on OKLO
Insider Buying and Selling at Oklo
In other Oklo news, insider William Carroll Murphy Goodwin sold 10,548 shares of the stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $58.04, for a total transaction of $612,205.92. Following the completion of the sale, the insider directly owned 36,175 shares of the company’s stock, valued at approximately $2,099,597. This trade represents a 22.58% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Craig Bealmear sold 73,081 shares of Oklo stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $68.42, for a total value of $5,000,202.02. Following the completion of the sale, the chief financial officer directly owned 397,642 shares in the company, valued at $27,206,665.64. This represents a 15.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 483,629 shares of company stock valued at $29,855,608 in the last ninety days. Insiders own 12.70% of the company’s stock.
Institutional Trading of Oklo
A number of institutional investors have recently modified their holdings of OKLO. Northwestern Mutual Wealth Management Co. increased its position in shares of Oklo by 6.6% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 2,800 shares of the company’s stock valued at $313,000 after buying an additional 174 shares in the last quarter. Kestra Advisory Services LLC boosted its position in shares of Oklo by 0.5% in the 4th quarter. Kestra Advisory Services LLC now owns 41,689 shares of the company’s stock worth $2,992,000 after buying an additional 197 shares in the last quarter. O Shaughnessy Asset Management LLC grew its stake in Oklo by 4.8% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 4,519 shares of the company’s stock valued at $324,000 after acquiring an additional 205 shares during the last quarter. Apexium Financial LP grew its stake in Oklo by 6.0% in the 3rd quarter. Apexium Financial LP now owns 4,000 shares of the company’s stock valued at $447,000 after acquiring an additional 225 shares during the last quarter. Finally, Comerica Bank increased its holdings in Oklo by 37.0% during the 3rd quarter. Comerica Bank now owns 981 shares of the company’s stock valued at $110,000 after acquiring an additional 265 shares in the last quarter. 85.03% of the stock is currently owned by hedge funds and other institutional investors.
Key Stories Impacting Oklo
Here are the key news stories impacting Oklo this week:
- Positive Sentiment: First quarterly revenue beat expectations. Oklo reported Q2 revenue of $1.21 million, far above the approximately $90,000 consensus estimate and up sharply year over year. The result provided an early indication of potential commercial activity, despite revenue remaining very small. Oklo Publishes Second Quarter 2026 Financial Results and Business Update
- Positive Sentiment: Groves reactor reached first criticality. Oklo’s Groves Isotope Test Reactor in Texas achieved a controlled, self-sustaining chain reaction at low power less than a year after groundbreaking. The DOE-authorized milestone supports initial isotope-production testing and strengthens the company’s technical and execution case for future reactor projects, including potential data-center power applications. Oklo’s Groves Reactor Achieves First Criticality in Under a Year
- Neutral Sentiment: Investors still face a long commercialization timeline. Management and market commentary indicate that meaningful power-generation revenue may not arrive until 2027–2028. Oklo’s substantial cash reserves provide funding for licensing, development and construction, but the stock’s valuation remains dependent on successful regulatory approvals and project execution. Oklo Q2 2026 Earnings Call Transcript
- Negative Sentiment: Quarterly losses were wider than expected. Oklo reported an adjusted loss of $0.28 per share versus the $0.16 consensus estimate, reflecting continued heavy development spending. The company remains unprofitable, making future financing needs and execution particularly important for shareholders. Oklo Quarterly Earnings Results
- Negative Sentiment: Insider selling remains a risk signal. Reported open-market activity over the past six months showed numerous insider sales and no purchases, including substantial sales by co-founders Jacob DeWitte and Caroline Cochran. This may weigh on sentiment, even though sales can also reflect scheduled transactions or diversification. Oklo Stock Opinions on Reactor Criticality Milestone
About Oklo
Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.
The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.
Featured Stories
- Five stocks we like better than Oklo
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.
